Drugs / IPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06331156 | Mar → Oct 2024 | gastroenteritis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06331156 ↗ |
| Modality | Vaccine | “Inactivated poliovirus vaccine (IPV) vaccine” NCT06331156 ↗ |
| Route | Intramuscular | “administered intramuscularly” NCT06331156 ↗ |